Cargando…

Targeted Overexpression of α-Synuclein by rAAV2/1 Vectors Induces Progressive Nigrostriatal Degeneration and Increases Vulnerability to MPTP in Mouse

Mutations, duplication and triplication of α-synuclein genes are linked to familial Parkinson’s disease (PD), and aggregation of α-synuclein (α-syn) in Lewy bodies (LB) is involved in the pathogenesis of the disease. The targeted overexpression of α-syn in the substantia nigra (SN) mediated by viral...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Lian-Kun, Ma, Kai-Li, Yuan, Yu-He, Mu, Zheng, Song, Xiu-Yun, Niu, Fei, Han, Ning, Chen, Nai-Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483255/ https://www.ncbi.nlm.nih.gov/pubmed/26114655 http://dx.doi.org/10.1371/journal.pone.0131281

Ejemplares similares

Neuroprotective effects of GSK-343 in an in vivo model of MPTP-induced nigrostriatal degeneration
por: Mannino, Deborah, et al.
Publicado: (2023)

Protective Role of rAAV-NDI1, Serotype 5, in an Acute MPTP Mouse Parkinson's Model
por: Barber-Singh, Jennifer, et al.
Publicado: (2010)

rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration
por: Oliveras-Salvá, Marusela, et al.
Publicado: (2013)

Morphological and Behavioral Impact of AAV2/5-Mediated Overexpression of Human Wildtype Alpha-Synuclein in the Rat Nigrostriatal System
por: Gombash, Sara E., et al.
Publicado: (2013)

Performance of Cardiotropic rAAV Vectors Is Dependent on Production Method
por: Rao, Renuka, et al.
Publicado: (2022)

Inhibition of copper transporter 1 prevents α-synuclein pathology and alleviates nigrostriatal degeneration in AAV-based mouse model of Parkinson's disease
por: Gou, De-Hai, et al.
Publicado: (2020)

Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration
por: Mor, Danielle E., et al.
Publicado: (2017)

Robust Long-term Transduction of Common Marmoset Neuromuscular Tissue With rAAV1 and rAAV9
por: Okada, Hironori, et al.
Publicado: (2013)

Proteomics Analysis of Co-Purifying Cellular Proteins Associated with rAAV Vectors
por: Dong, Biao, et al.
Publicado: (2014)

Molecular design for recombinant adeno-associated virus (rAAV) vector production
por: Aponte-Ubillus, Juan Jose, et al.
Publicado: (2017)

An efficient rAAV vector for protein expression in cortical parvalbumin expressing interneurons
por: Tkatch, Tatiana, et al.
Publicado: (2022)

Long-term, efficient inhibition of microRNA function in mice using rAAV vectors
por: Xie, Jun, et al.
Publicado: (2012)

TGF‐β gene transfer and overexpression via rAAV vectors stimulates chondrogenic events in human bone marrow aspirates
por: Frisch, Janina, et al.
Publicado: (2016)

Minocycline inhibition of microglial rescues nigrostriatal dopaminergic neurodegeneration caused by mutant alpha-synuclein overexpression
por: Wang, Yong, et al.
Publicado: (2020)

Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression
por: Bourdenx, Mathieu, et al.
Publicado: (2015)

The anti-tumor effect and increased tregs infiltration mediated by rAAV-SLC vector
por: Li, Rilun, et al.
Publicado: (2013)

Gene Delivery to Adipose Tissue Using Transcriptionally Targeted rAAV8 Vectors
por: Uhrig-Schmidt, Silke, et al.
Publicado: (2014)

Identification of Novel Retinal Pericyte-Targeting rAAV Vectors Through Directed Evolution
por: Patel, Dwani D., et al.
Publicado: (2022)

Differential effects of two MRI contrast agents on the integrity and distribution of rAAV2 and rAAV5 in the rat striatum
por: Osting, Sue, et al.
Publicado: (2014)

Impact of mechanical stimulation on the chondrogenic processes in human bone marrow aspirates modified to overexpress sox9 via rAAV vectors
por: Venkatesan, Jagadeesh K., et al.
Publicado: (2017)

Dynamic Changes in the Nigrostriatal Pathway in the MPTP Mouse Model of Parkinson's Disease
por: Huang, Dongping, et al.
Publicado: (2017)

rAAV8 and rAAV9-Mediated Long-Term Muscle Transduction with Tacrolimus (FK506) in Non-Human Primates
por: Ishii, Akiko, et al.
Publicado: (2020)

Serotype-specific Binding Properties and Nanoparticle Characteristics Contribute to the Immunogenicity of rAAV1 Vectors
por: Ferrand, Maxime, et al.
Publicado: (2015)

Origins of truncated supplementary capsid proteins in rAAV8 vectors produced with the baculovirus system
por: Galibert, Lionel, et al.
Publicado: (2018)

Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?
por: Zhan, Wei, et al.
Publicado: (2021)

AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson’s disease
por: Ip, Chi Wang, et al.
Publicado: (2017)

Nigrostriatal dynein changes in A53T alpha-synuclein transgenic mice
por: Liu, Yan, et al.
Publicado: (2014)

Extracorporeal Delivery of rAAV with Metabolic Exchange and Oxygenation
por: Bieber, Scott, et al.
Publicado: (2013)

rAAV-delivered PTEN therapeutics for prostate cancer
por: Ai, Jianzhong, et al.
Publicado: (2021)

rAAV-mediated overexpression of TGF-β stably restructures human osteoarthritic articular cartilage in situ
por: Venkatesan, Jagadeesh K, et al.
Publicado: (2013)

MPTP-induced vulnerability of dopamine neurons in A53T α-synuclein overexpressed mice with the potential involvement of DJ-1 downregulation
por: Lee, Seongmi, et al.
Publicado: (2017)

VectorMOD: Method for Bottom-Up Proteomic Characterization of rAAV Capsid Post-Translational Modifications and Vector Impurities
por: Rumachik, Neil G., et al.
Publicado: (2021)

High-Level rAAV Vector Production by rAdV-Mediated Amplification of Small Amounts of Input Vector
por: Weger, Stefan
Publicado: (2022)

TGF-β1 and TIMP1 double directional rAAV targeted by UTMD in atherosclerotic vulnerable plaque
por: Su, Yijin, et al.
Publicado: (2017)

Immune Responses to rAAV6: The Influence of Canine Parvovirus Vaccination and Neonatal Administration of Viral Vector
por: Arnett, Andrea L. H., et al.
Publicado: (2011)

Controlled Release of rAAV Vectors from APMA-Functionalized Contact Lenses for Corneal Gene Therapy
por: Alvarez-Rivera, Fernando, et al.
Publicado: (2020)

Regulated hAAT Expression from a Novel rAAV Vector and Its Application in the Prevention of Type 1 Diabetes
por: Ma, Hongxia, et al.
Publicado: (2019)

Immunomodulation in Administration of rAAV: Preclinical and Clinical Adjuvant Pharmacotherapies
por: Chu, Wing Sum, et al.
Publicado: (2021)

Monobac System–A Single Baculovirus for the Production of rAAV
por: Galibert, Lionel, et al.
Publicado: (2021)

Durability of transgene expression after rAAV gene therapy
por: Muhuri, Manish, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uc59jvb3oo3h1ueqcp6rjr4ebc